{"date":"2026-06-20","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6467-2026-06-20-0852-13us9qs","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-06-20","time":"08:52:09","subject":"公告本公司TAH3311抗血栓口溶膜 505(b)(2)新劑型新藥已重新向美國食品藥物管理局(FDA)遞送藥證申請(NDA)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-06-20 08:52，「公告本公司TAH3311抗血栓口溶膜 505(b)(2)新劑型新藥已重新向美國食品藥物管理局(FDA)遞送藥證申請(ND」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}